Cooper's Lack of Strategic Focus, Misaligned Incentives, and Inadequate Board Oversight Have Led to Meaningful Underperformance Current Corporate Structure Obscures Value of Both CooperVision and CooperSurgical; Refocus as a Pure Play Vision Care Company Under a Refreshed Board May Lead to More Than a Doubling of Cooper's Stock Price Urges Cooper's Board to Appoint Browning West’s Highly Skilled Director Candidates Who Will... Read More

SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results on Thursday, December 4, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is... Read More

SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company’s share repurchase program. The share repurchase program now totals $2 billion. “We are pleased to announce that our Board of Directors has authorized an increase to our share repurchase program,” said Al White,... Read More

SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025. Revenue increased 6% year-over-year to $1,060.3 million. CooperVision (CVI) revenue up 6% to $718.4 million, and CooperSurgical (CSI) revenue up 4% to $341.9 million. GAAP diluted earnings per share (EPS) of $0.49, down... Read More

TORONTO , Aug. 18, 2025 /CNW/ - For the fifth year in a row, CooperVision Canada is investing in educating parents and raising awareness about myopia (aka nearsightedness) in children, emphasizing that it is more than just a blurry vision issue, it is a progressive condition that requires proactive management to help protect long-term eye health and preserve future opportunities for children. MiSight ® 1 day contact lenses... Read More

SAN RAMON, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025. Al White, President and CEO, will represent the Company in a session scheduled at 3:00 PM ET. The webcast will be available to investors and other interested parties by accessing the... Read More

SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, August 27, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the... Read More

SAN RAMON, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025. Revenue increased 6% year-over-year to $1,002.3 million. CooperVision (CVI) revenue up 5% to $669.6 million, and CooperSurgical (CSI) revenue up 8% to $332.7 million. GAAP diluted earnings per share (EPS) of $0.44,... Read More

SAN RAMON, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (“Cooper”) (Nasdaq: COO), a leading medical device company, published its 2024 Sustainability Report . The report showcases the company’s initiatives to foster positive change for both people and the planet and provides expanded and updated sustainability performance data. In 2024, CooperCompanies maintained strong partnerships to reduce its plastic... Read More

SAN RAMON, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the William Blair Growth Stock Conference on Thursday, June 5, 2025. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 11:20 AM CT. The webcast will be available to investors and other... Read More

SAN RAMON, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Barbara Carbone as an independent director, effective May 1, 2025. Ms. Carbone has also been appointed to serve on the Audit Committee when she joins the Board. Ms. Carbone brings nearly four decades of experience across a wide variety of... Read More

SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the... Read More

SAN RAMON, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2025. Revenue increased 4% year-over-year to $964.7 million. CooperVision (CVI) revenue up 4% to $646.1 million, and CooperSurgical (CSI) revenue up 3% to $318.6 million. GAAP diluted earnings per share (EPS) of $0.52, up... Read More

SAN RAMON, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2025 financial results on Thursday, March 6, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7466264. A simultaneous... Read More

SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET. A live and archived webcast of this event, where applicable, will be available by accessing the... Read More

SAN RAMON, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2024. Fourth quarter 2024 revenue of $1,018.4 million, up 10%, or up 7% organically. Fiscal year 2024 revenue of $3.9 billion, up 8%, or up 8% organically. Fourth quarter 2024 GAAP diluted earnings per share... Read More

SAN RAMON, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report fourth quarter and full year 2024 financial results on Thursday, December 5, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is... Read More

SAN RAMON, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) announced today that the company has been recognized as a Best Workplace for Innovators by Fast Company— a leading business media brand with an editorial focus on innovation—for creating a culture of employee development and belonging that inspires innovation and the development of new products and advocacy initiatives that aim to improve... Read More

The simplified insertion process is a milestone innovation for the market’s leading hormone-free contraceptive, with an efficacy rate greater than 99% 1,2 TRUMBULL, Conn. / Sep 03, 2024 / Business Wire / CooperSurgical , a global leader in women’s healthcare, today announced the launch of a new inserter designed for single-hand placement of Paragard®, which was recently approved by the U.S. Food and Drug Administration... Read More

SAN RAMON, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024. Revenue increased 8% year-over-year to $1,002.8 million. CooperVision (CVI) revenue up 7% to $675.6 million, and CooperSurgical (CSI) revenue up 9% to $327.2 million. GAAP diluted earnings per share (EPS) of $0.52, up... Read More

SAN RAMON, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced its participation in the following upcoming investor conferences: 2024 Wells Fargo Healthcare Conference Wednesday, September 4, 2024, at 3:45 pm ET Al White, President & Chief Executive Officer, will represent the Company in a fireside chat Morgan Stanley Annual Global Healthcare... Read More

SAN RAMON, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report third quarter 2024 financial results on Wednesday, August 28, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7528310. A... Read More

SAN RAMON, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), today announced that CooperSurgical has acquired obp Surgical, a U.S.-based medical device company with a suite of single-use cordless surgical retractors with an integrated multi-LED light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source, for approximately... Read More

SAN RAMON, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2024. Revenue increased 7% year-over-year to $942.6 million. CooperVision (CVI) revenue up 8% to $635.9 million, and CooperSurgical (CSI) revenue up 6% to $306.7 million. GAAP diluted earnings per share (EPS) of $0.44, up... Read More

SAN RAMON, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today released its 2023 Environmental, Social, and Governance (ESG) Report . The report showcases the company’s progress on enhancing the health and wellness of people around the world, while doing its part to protect the planet and serve its communities. In 2023, CooperCompanies continued to make its leading healthcare solutions more... Read More

SAN RAMON, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 1:30 PM ET. The webcast will be available to investors and other interested... Read More

SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled at 11:00 AM ET. The webcast will be available to investors and other interested parties by... Read More

SAN RAMON, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report second quarter 2024 financial results on Thursday, May 30, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 1712676. A simultaneous... Read More

SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million. GAAP diluted earnings per share (EPS) of $0.41,... Read More

SAN RAMON, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced that its four-for-one stock split will become effective on Friday, February 16, 2024, at 5:00 PM ET, and trading is expected to begin on a stock split-adjusted basis at market open on Tuesday, February 20, 2024, under the existing trading symbol “COO”. The stock split supports Cooper’s desire to make ownership of its stock more... Read More

Testing offers CBR families the opportunity to proactively seek additional information about their child's health ‍TRUMBULL, Conn. and EL MONTE, Calif. , Feb. 9, 2024 /PRNewswire/ -- CooperSurgical ® , a global leader in fertility and women's health, and Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today... Read More

SAN RAMON, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2024 financial results on Thursday, February 29, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 5337119. A... Read More

SAN RAMON, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website... Read More

SAN RAMON, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Cooper Companies (Nasdaq: COO) announced today that it will hold its next annual meeting of stockholders on Tuesday, March 19, 2024. Stockholders of record as of the close of business on January 24, 2024, will be eligible to vote on matters presented in the Company's proxy statement, including electing its slate of directors. About CooperCompanies CooperCompanies (Nasdaq:... Read More

SAN RAMON, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2023. Fourth quarter 2023 revenue of $927.1 million, up 9%, and up 9% organically. Fiscal year 2023 revenue of $3.6 billion, up 9%, or up 10% organically. Fourth quarter 2023 GAAP diluted earnings per share... Read More

SAN RAMON, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) announced today that its Board of Directors has appointed Lawrence E. Kurzius as an independent director, effective December 1, 2023. Kurzius has also been appointed to serve on the Audit Committee and Organization & Compensation Committee when he joins the Board. “We are thrilled to welcome Lawrence to our Board of Directors,” said Al White,... Read More

SAN RAMON, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report fourth quarter and full year 2023 financial results on Thursday, December 7, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is... Read More

SAN RAMON, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), today announced that it will transfer the listing of its common stock from the New York Stock Exchange (“NYSE”) to the Nasdaq Stock Market (“Nasdaq”). Cooper expects to begin trading as a Nasdaq-listed company at market open on September 26, 2023, and will continue to trade under the symbol “COO.” “We are excited to join many of the world’s... Read More

SAN RAMON, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Baird Healthcare Conference on Wednesday, September 13, 2023. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled to begin at 1:25 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’... Read More

Marquee industry conference will showcase data from CBR's Newborn Possibilities Program ® TRUMBULL, Conn. , Sept. 8, 2023 /PRNewswire/ -- CooperSurgical, a global leader in fertility and women's health, announced that Cord Blood Registry ® (CBR ® ) will have a key role in the upcoming Cord Blood Connect meeting from September 8 th – 11 th , which is the annual meeting of the Cord Blood Association. The Cord Blood Association... Read More

SAN RAMON, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal third quarter ended July 31, 2023. Revenue increased 10% year-over-year to $930.2 million. CooperVision (CVI) revenue up 11% to $630.2 million, and CooperSurgical (CSI) revenue up 8% to $300.0 million. GAAP diluted earnings per share (EPS) of $1.71, down $0.27 or 14% from last year's third... Read More

SAN RAMON, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Wells Fargo Healthcare Conference on Wednesday, September 6, 2023. Al White, President and CEO, will represent the Company in a session scheduled to begin at 3:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com . A... Read More

Banking newborn stem cells an option for couples choosing gestational carrier TRUMBULL, Conn. , July 27, 2023 /PRNewswire/ -- CooperSurgical , a global leader in fertility and women's health, announced that Chrissy Teigen , mom, New York Times best-selling cookbook author, television host and entrepreneur, selected Cord Blood Registry® (CBR®) to bank the umbilical cord blood and cord tissue of her newborn, Wren Alexander... Read More

SAN RAMON, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will report third quarter 2023 financial results on Wednesday, August 30, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 5988827. A simultaneous... Read More

SAN RAMON, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 11, 2023, to stockholders of record on July 27, 2023. About CooperCompanies CooperCompanies ("Cooper") is a global medical device company publicly traded on... Read More

SAN RAMON, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal second quarter ended April 30, 2023. Revenue increased 6% year-over-year to $877.4 million. CooperVision (CVI) revenue up 6% to $589.3 million, and CooperSurgical (CSI) revenue up 4% to $288.1 million. GAAP diluted earnings per share (EPS) of $0.80, down $1.75 or 69% from last year's second... Read More

SAN RAMON, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 8, 2023. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled to begin at 2:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at... Read More

Prestigious international awards program recognizes standout digital health and medical technology products and companies ‍TRUMBULL, Conn. , May 16, 2023 /PRNewswire/ -- CooperSurgical , a global leader in women's healthcare, and Ostro , a healthcare engagement platform for consumers and healthcare providers, have been selected as "Best Patient Education Solution" in the 7 th annual MedTech Breakthrough Awards. This year... Read More

SAN RAMON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today released its 2022 Environmental, Social, and Governance (ESG) Report . It highlights the company's progress on social and environmental issues most important to its businesses and stakeholders, including employees, shareholders, customers, and global communities. In 2022, CooperCompanies manufactured a record number of products while... Read More

SAN RAMON, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will report second quarter 2023 financial results on Thursday, June 1, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7116518. A simultaneous... Read More

CooperSurgical to match portion of sales and donate to RESOLVE aiding in raising awareness and destigmatizing infertility TRUMBULL, Conn. , April 25, 2023 /PRNewswire/ -- CooperSurgical , a global leader in fertility and women's health, today announced they are partnering with The Noble Paperie, which makes cards & paper... Read More

SAN RAMON, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal first quarter ended January 31, 2023. Revenue increased 9% year-over-year to $858.5 million. CooperVision (CVI) revenue up 4% to $581.3 million, and CooperSurgical (CSI) revenue up 23% to $277.2 million. GAAP diluted earnings per share (EPS) of $1.70, down $0.21 or 11% from last year's first... Read More

First 1-Day Lens that Combines Innovative DigitalBoost™ & Aquaform® Technologies Designed to Deliver Extraordinary Comfort for Patients' 'Always On' Digital Lifestyles SAN RAMON, Calif. , March 1, 2023 /PRNewswire/ -- Signaling a new advancement in addressing the symptoms of pervasive digital eye strain, CooperVision® MyDay Energys® contact lenses are now available to all eye care professionals across the United States . The... Read More

SAN RAMON, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in KeyBanc’s Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 1:30 PM ET. The webcast will be available to investors and other interested parties by accessing the... Read More

SAN RAMON, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in Oppenheimer’s 33 rd Annual Healthcare Conference on Tuesday, March 14, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 2:40 PM ET. The webcast will be available to investors and other interested parties by accessing the... Read More

SAN RAMON, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will report first quarter 2023 financial results on Thursday, March 2, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 1757767. A simultaneous... Read More

Updated Guidance Reflects Real World Impact of Technology TRUMBULL, Conn. , Jan. 19, 2023 /PRNewswire/ -- CooperSurgical , a global leader in fertility and women's health, today shared that the National Institute for Health and Care Excellence (NICE) recommended Fetal Pillow to be used under standard arrangements during delivery if a baby's head becomes stuck in the pelvis. NICE provides national guidance and advice to... Read More

Program provides free access to qualifying families in need TRUMBULL, Conn. , Jan. 5, 2023 /PRNewswire/ -- CooperSurgical , a global leader in fertility and women's health, today shared that more than 11,000 families have enrolled in the Newborn Possibilities Program ® through their Cord Blood Registry ® (CBR ® ) brand. Through the Newborn Possibilities Program, CBR offers free cord blood and tissue processing and five years... Read More

SAN RAMON, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that it will hold its next annual meeting of stockholders on Wednesday, March 15, 2023. Stockholders of record as of the close of business on January 19, 2023, will be eligible to vote on matters presented in the Company's proxy statement, including electing its slate of directors. About CooperCompanies CooperCompanies ("Cooper")... Read More

SAN RAMON, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 10, 2023, to stockholders of record on January 23, 2023. About CooperCompanies CooperCompanies ("Cooper") is a global medical device company publicly... Read More

Technology partnership aims to increase engagement by educating consumers about CooperSurgical's Paragard TRUMBULL, Conn. , Dec. 14, 2022 /PRNewswire/ -- CooperSurgical, Inc. , a leader in women's healthcare, and Ostro , a leading engagement platform dedicated to educating and empowering consumers and healthcare providers, today announced their partnership to launch a new consumer engagement solution for CooperSurgical's... Read More